This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Yuko Shichijo: Innovator in Ophthalmic Treatments
Introduction
Yuko Shichijo is a prominent inventor based in Nara, Japan. She has made significant contributions to the field of ophthalmology, particularly in the treatment of dry eye syndrome. Her innovative approach combines pharmacological agents to enhance tear secretion and improve corneal health.
Latest Patents
Yuko Shichijo holds a patent for an agent designed for the treatment of dry eye. This agent comprises a combination of a P2Y receptor agonist and hyaluronic acid or a salt thereof, both at therapeutically effective concentrations. The formulation is designed as an ophthalmic agent that remarkably promotes tear secretion and improves corneal epithelial disorders. This novel agent is expected to provide a new avenue for treating dry eye conditions.
Career Highlights
Yuko Shichijo is associated with Santen Pharmaceutical Co., Ltd., a company known for its focus on ophthalmic products. Her work has been instrumental in advancing therapeutic options for patients suffering from dry eye syndrome. With her expertise, she has contributed to the development of effective treatments that enhance patient quality of life.
Collaborations
Yuko has collaborated with notable colleagues, including Atsuyoshi Dota and Takashi Nagano. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of ophthalmology.
Conclusion
Yuko Shichijo's contributions to ophthalmic treatments, particularly for dry eye syndrome, highlight her role as an influential inventor in the medical field. Her innovative patent reflects her commitment to improving patient care through scientific advancements.